Hookipa Pharma Inc Expected To Post A Loss Of 36 Cents A Share: Earnings Preview

Hookipa Pharma

09/08/2022 17:40

* HOOKIPA Pharma Inc  HOOK.OQ   HOOK.O  is expected to show
a fall
in quarterly revenue when it reports  results on August 11. 
    * The New York City-based  company is expected to report  a
33.9% decrease in revenue to $3.558 million from $5.38 million a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for HOOKIPA Pharma Inc
is for
a loss of 36 cents per share. For the same quarter last year,
the company reported a loss of 52 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for HOOKIPA
Pharma
Inc is $6​, above​ its last closing price of $1.56. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -0.24       -0.24      -0.40     Missed  -66.7
 Dec. 31 2022  -0.63       -0.58      -0.65     Missed  -12.3
 Sep. 30 2021  -0.52       -0.52      -0.61     Missed  -16.6​
 Jun. 30 2021  -0.53       -0.53      -0.52     Beat    1.6
 ​​Mar.        -0.52       -0.53      -0.53     Met     0.6
 31 2021                                                
 Dec. 31 2020  -0.54       -0.58      -0.46     Beat    21.4​
 Sep. 30 2020  -0.44       -0.43      -0.53     Missed  -22.8
 Jun. 30 2020  -0.49       -0.47      -0.28     Beat    40.1
 This summary was machine generated August 9 at 16:40 GMT.  All
figures in US dollars  unless otherwise stated